论文期刊

取消

高级检索

检索历史清除

首页> Pregnancy hypertension> First trimester placental vascularization and angiogenetic factors are associated with adverse pregnancy outcome.

First trimester placental vascularization and angiogenetic factors are associated with adverse pregnancy outcome.

导出 LinkOut

翻译打印收藏纠错

作者： Johanna E W,Leijnse ^[1] ; Roel,de Heus ^[2] ; Wilco,de Jager ^[3] ; Wendy,Rodenburg ^[4] ; Louis L H,Peeters ^[2] ; Arie,Franx ^[2] ; Niels,Eijkelkamp ^[5]

作者单位： Department of Obstetrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, 3508 GA Utrecht, The Netherlands. Electronic address: jleijnse@rkz.nl. ^[1] Department of Obstetrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, 3508 GA Utrecht, The Netherlands. ^[2] Department of Pediatric Immunology, Laboratory of Translational Immunology and Multiplex Core Facility, Wilhelmina Children's Hospital, University Medical Centre Utrecht, 3584 CX Utrecht, The Netherlands. ^[3] National Institute for Public Health and Environment (RIVM), 3721 MA Bilthoven, The Netherlands. ^[4] Laboratory of Neuroimmunology and Developmental Origins of Disease (NIDOD), Wilhelmina Children's Hospital, University Medical Centre Utrecht, 3584 EA Utrecht, The Netherlands. ^[5]

关键词 3D power Doppler Angiopoietin 1 Angiopoietin 2 Fetal growth restriction Flow index Hypertensive disorders Leptin Placental abruption Placental vascularization Preeclampsia Preterm birth Vascularization flow index Vascularization index

主题词成年人(Adult);血管生成素1(Angiopoietin-1);女(雌)性(Female);人类(Humans);瘦素(Leptin);纵向研究(Longitudinal Studies);胎盘(Placenta);先兆子痫(Pre-Eclampsia);妊娠(Pregnancy);妊娠结局(Pregnancy Outcome);妊娠初期(Pregnancy Trimester, First);前瞻性研究(Prospective Studies);超声检查, 产前(Ultrasonography, Prenatal);血管内皮生长因子A(Vascular Endothelial Growth Factor A)

DOI 10.1016/j.preghy.2018.04.008

PMID 30177079

发布时间 2018-11-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览8

Pregnancy hypertension

87-94页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览8

Pregnancy hypertension

87-94页

相关期刊

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷